Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126661) titled 'A Two-Cohort, Multicenter, Prospective Phase II Clinical Study of Radiation Therapy Combined with iparomlimab and tuvonralimab (QL1706) in the Treatment of Treatment-Naive/First-Line Failure Advanced Unresectable Hepatocellular Carcinoma' on June 12.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Guangxi Medical University Cancer Hospital
Condition:
Hepatocellular carcinoma
Intervention:
First-line treatment cohort:Oxaliplatin-based systemic chemotherapy, atezolizumab combined with bevacizumab, sintilimab combined with bevacizumab biosimilar, apatinib combined with ...